HPR32 An Assessment of Breast Cancer Drug Innovation in the United States (1980-2021)

Abstract

Authors

A Althomali M Al ghamdi E Althagafi E Seoane-Vazquez

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×